Ignite Creation Date:
2025-12-24 @ 7:15 PM
Ignite Modification Date:
2025-12-29 @ 5:16 PM
Study NCT ID:
NCT01063803
Status:
COMPLETED
Last Update Posted:
2016-04-11
First Post:
2010-02-02
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study Evaluating Long-Term Safety Of ATN-103 In Subjects With Rheumatoid Arthritis
Sponsor:
Ablynx, a Sanofi company
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
3242K1-2003
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None